Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi Center, Phase III Clinical Trial to Evaluate the Safety and Efficacy of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

NCT05289921 is registered in ClinicalTrials.gov with Huons Co., Ltd. as lead sponsor.

NCT NCT05289921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05289921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi Center, Phase III Clinical Trial to Evaluate the Safety and Efficacy of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity
Lead sponsor
Huons Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
March 4, 2022
Completion date
March 7, 2023
Enrollment
198 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post stroke upper limb spasticity